TEL: +86-21-50180596 Email: sales@biopharmaleader.com

Search

Contact Us

Tel: 0086 21 50180596

Fax: 0086 21 57758967

Mob: 0086 18721201413

E-mail:sales@biopharmaleader.com

Bioactive Molecules

Oritavancin CAS:171099-57-3

Oritavancin  CAS:171099-57-3


Product Information

CAS NO.171099-57-3 1.png
Product NameOritavancin
SynonymsLY 333328
FormulaC86H97Cl3N10O26
Molecular Weight1793.12
Spec / Purity98%min
Supply Capacity
DetailsOritavancin (LY333328/Orbactiv) is a novel semisynthetic glycopeptide antibiotic being developed for the treatment of serious Gram-positive bacterial infections. In December 2008, the US FDA declined to approve it without additional studies, and an EU application was withdrawn. In 2009, the development rights were acquired by The Medicines Company, which has completed clinical trials and submitted a new drug application to the FDA in February 2014. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections in the United States. Its chemical structure is similar to vancomycin. It is a lipoglycopeptide.

If you are going to consult the information about oritavancin cas:171099-57-3 from one of the leading Bioactive Molecules manufacturers and suppliers in China, It is always at your service.

Shanghai Biopharmaleader Co.,Ltd